Characterization of Clostridioides difficile Isolates Available through the CDC & FDA Antibiotic Resistance Isolate Bank.

Ashley PaulickMichelle AdamczykKaren AndersonNick VlachosMaría-José MachadoGillian McAllisterLauren KorhonenAlice Y GuhAlison Laufer HalpinJ Kamile RasheedMaria Karlsson Joseph D Lutgring Amy S Gargisnull null

Published in: Microbiology resource announcements (2021)

Thirty Clostridioides difficile isolates collected in 2016 through the Centers for Disease Control and Prevention Emerging Infections Program were selected for reference antimicrobial susceptibility testing and whole-genome sequencing. Here, we present the genetic characteristics of these isolates and announce their availability in the CDC & FDA Antibiotic Resistance Isolate Bank.

Keyphrases

clostridium difficile
genetic diversity
cell cycle
quality improvement
genome wide
copy number
dna methylation